dual acting anti-inflammatory agents/histamine H1 receptor antagonists (Hefei Industrial Pharmaceutical Institute)

N/A

Report date: 2025/03/19 08:56:54
NME

Base Information

Drug Namedual acting anti-inflammatory agents/histamine H1 receptor antagonists (Hefei Industrial Pharmaceutical Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHefei Industrial Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHefei Industrial Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A